Clinical trial
Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women…
NCT00270530 · Center for International Health and Development, Other · Completed
Key facts
| NCT number | NCT00270530 |
|---|---|
| Title | Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia |
| Official title | Intermittent Preventive Treatment of Malaria With Sulfadoxine-Pyrimethamine in HIV-Seropositive and HIV-Seronegative Pregnant Women in Zambia |
| Lead sponsor | Center for International Health and Development, Other |
| Collaborators | Centers for Disease Control and Prevention U.S. Fed |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Placental Malaria Infection, HIV Infections, Stillbirth, Prematurity, Neonatal Deaths |
| Intervention type | Drug |
| Interventions | Sulfadoxine-pyrimethamine (Fansidar) |
| Enrollment | 454 |
| Start date | Nov 1, 2002 |
| Completion | Oct 1, 2004 |
| First posted | Dec 28, 2005 |
| Last update posted | Jan 31, 2006 |
| Countries | Zambia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: